These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12754307)

  • 1. Five ADNFLE mutations reduce the Ca2+ dependence of the mammalian alpha4beta2 acetylcholine response.
    Rodrigues-Pinguet N; Jia L; Li M; Figl A; Klaassen A; Truong A; Lester HA; Cohen BN
    J Physiol; 2003 Jul; 550(Pt 1):11-26. PubMed ID: 12754307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations linked to autosomal dominant nocturnal frontal lobe epilepsy affect allosteric Ca2+ activation of the alpha 4 beta 2 nicotinic acetylcholine receptor.
    Rodrigues-Pinguet NO; Pinguet TJ; Figl A; Lester HA; Cohen BN
    Mol Pharmacol; 2005 Aug; 68(2):487-501. PubMed ID: 15901849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response.
    Figl A; Viseshakul N; Shafaee N; Forsayeth J; Cohen BN
    J Physiol; 1998 Dec; 513 ( Pt 3)(Pt 3):655-70. PubMed ID: 9824708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.
    Nichols WA; Henderson BJ; Marotta CB; Yu CY; Richards C; Dougherty DA; Lester HA; Cohen BN
    PLoS One; 2016; 11(6):e0158032. PubMed ID: 27336596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
    Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
    Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors.
    Kuryatov A; Gerzanich V; Nelson M; Olale F; Lindstrom J
    J Neurosci; 1997 Dec; 17(23):9035-47. PubMed ID: 9364050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy.
    Weltzin MM; Lindstrom JM; Lukas RJ; Whiteaker P
    Neuropharmacology; 2016 Mar; 102():158-73. PubMed ID: 26561946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How mutations in the nAChRs can cause ADNFLE epilepsy.
    Bertrand D; Picard F; Le Hellard S; Weiland S; Favre I; Phillips H; Bertrand S; Berkovic SF; Malafosse A; Mulley J
    Epilepsia; 2002; 43 Suppl 5():112-22. PubMed ID: 12121305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine.
    Picard F; Bertrand S; Steinlein OK; Bertrand D
    Epilepsia; 1999 Sep; 40(9):1198-209. PubMed ID: 10487182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation (Ser284Leu) of neuronal nicotinic acetylcholine receptor alpha 4 subunit associated with frontal lobe epilepsy causes faster desensitization of the rat receptor expressed in oocytes.
    Matsushima N; Hirose S; Iwata H; Fukuma G; Yonetani M; Nagayama C; Hamanaka W; Matsunaka Y; Ito M; Kaneko S; Mitsudome A; Sugiyama H
    Epilepsy Res; 2002 Feb; 48(3):181-6. PubMed ID: 11904236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy.
    Bertrand S; Weiland S; Berkovic SF; Steinlein OK; Bertrand D
    Br J Pharmacol; 1998 Oct; 125(4):751-60. PubMed ID: 9831911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy.
    Phillips HA; Favre I; Kirkpatrick M; Zuberi SM; Goudie D; Heron SE; Scheffer IE; Sutherland GR; Berkovic SF; Bertrand D; Mulley JC
    Am J Hum Genet; 2001 Jan; 68(1):225-31. PubMed ID: 11104662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of mutated murine alpha4beta2 nicotinic receptors linked to partial epilepsy.
    Lipovsek M; Plazas P; Savino J; Klaassen A; Boulter J; Elgoyhen AB; Katz E
    Neurosci Lett; 2008 Mar; 434(2):165-9. PubMed ID: 18321647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role in the selectivity of neonicotinoids of insect-specific basic residues in loop D of the nicotinic acetylcholine receptor agonist binding site.
    Shimomura M; Yokota M; Ihara M; Akamatsu M; Sattelle DB; Matsuda K
    Mol Pharmacol; 2006 Oct; 70(4):1255-63. PubMed ID: 16868180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study.
    Picard F; Bruel D; Servent D; Saba W; Fruchart-Gaillard C; Schöllhorn-Peyronneau MA; Roumenov D; Brodtkorb E; Zuberi S; Gambardella A; Steinborn B; Hufnagel A; Valette H; Bottlaender M
    Brain; 2006 Aug; 129(Pt 8):2047-60. PubMed ID: 16815873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep-related hypermotor epilepsy associated mutations uncover important kinetic roles of α4β2- nicotinic acetylcholine receptor intracellular structures.
    Weltzin MM; George AA; Lukas RJ; Whiteaker P
    PLoS One; 2021; 16(3):e0247825. PubMed ID: 33657187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive single-channel properties of α4β2-nicotinic acetylcholine receptor isoforms.
    Weltzin MM; George AA; Lukas RJ; Whiteaker P
    PLoS One; 2019; 14(3):e0213143. PubMed ID: 30845161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy.
    Klaassen A; Glykys J; Maguire J; Labarca C; Mody I; Boulter J
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19152-7. PubMed ID: 17146052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit.
    Biaggi-Labiosa NM; Avilés-Pagán E; Caballero-Rivera D; Báez-Pagán CA; Lasalde-Dominicci JA
    Neuropharmacology; 2015 Dec; 99():273-84. PubMed ID: 25957813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
    Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
    Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.